NeuBase Announces 1-for-20 Reverse Stock Split
Portfolio Pulse from Benzinga Newsdesk
NeuBase Therapeutics announced a 1-for-20 reverse stock split, which will reduce the number of outstanding shares and increase the stock price proportionally.

June 14, 2023 | 12:35 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
NeuBase Therapeutics' 1-for-20 reverse stock split will reduce the number of outstanding shares and increase the stock price proportionally.
The reverse stock split will reduce the number of outstanding shares, which will increase the stock price proportionally. This action is typically taken to meet minimum stock price requirements for exchanges or to attract institutional investors. However, it does not change the company's market capitalization or the value of an investor's holdings. Therefore, the short-term impact on the stock price is neutral.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100